Phase I Safety Study of DMXAA in Refractory Tumors

Clinical trial NCT00856336 · COMPLETED

Trial details

NCT number: NCT00856336
Sponsor: Antisoma Research
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Tumors

Start date: 2003-05-01
Primary completion: 2004-01-01
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.